Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS)

被引:360
作者
Locatelli, F
Pisoni, RL
Combe, C
Bommer, J
Andreucci, VE
Piera, L
Greenwood, R
Feldman, HI
Port, FK
Held, PJ
机构
[1] Univ Renal Res & Educ Assoc, Ann Arbor, MI 48103 USA
[2] A Manzoni Hosp, Dept Nephrol & Dialysis, Lecce, Italy
[3] Hop St Andre, Nephrol & Hemodialysis Serv, Bordeaux, France
[4] Heidelberg Univ, Nephrol Sect, Heidelberg, Germany
[5] Univ Naples Federico II, Dept Nephrol, Naples, Italy
[6] Hosp Gen Valle Hebron, Serv Nephrol, Barcelona, Spain
[7] Lister Hosp, Dept Renal Med, Stevenage, Herts, England
[8] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
关键词
anaemia; chronic kidney disease; morbidity; mortality; haemodialysis; rHuEpo;
D O I
10.1093/ndt/gfg458
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. The Dialysis Outcomes and Practice Patterns Study (DOPPS) is a prospective, observational study based on data collected from nationally representative samples of haemodialysis facilities. The burden of anaemia in haemodialysis patients is substantial, leading to considerable morbidity, mortality and reduced quality of life. This study examines anaemia management and outcomes based on data from five European countries participating in the DOPPS: France, Germany, Italy, Spain and the UK. Methods. Baseline data on demographics, co-morbidities and anaemia management in 4591 haemodialysis patients from 101 nephrology facilities were collected in 1998-2000. Using multivariate Cox survival analyses to adjust for patient characteristics, relationships between haemoglobin concentration at study entry and rates of mortality and hospitalization were evaluated. Results. For a year 2000 sample of prevalent patients on haemodialysis > 180 days, mean haemoglobin concentration was 11.0 g/dl; 53% had a haemoglobin concentration greater than or equal to11 g/dl [1998-1999 = 44% (P < 0.05)]. In 2000, 84% of prevalent patients were prescribed recombinant human erythropoietin (rHuEpo). Higher haemoglobin concentrations were associated with decreased relative risk (RR) for mortality (RR = 0.95 for every I g/dl higher haemoglobin, P=0.03) and hospitalization (RR=0.96, P=0.02). Patients with haemoglobin < 10 g/dl were 29% more likely to be hospitalized than patients with haemoglobin 11-12 g/dl (P < 0.001). Conclusion. Even after adjustment, lower haemoglobin concentrations were associated with higher morbidity and mortality in European haemodialysis patients. A trend to increased haemoglobin concentrations was observed following publication of the European Best Practice Guidelines (EBPG) on anaemia management for chronic kidney disease patients, but efforts must continue to achieve EBPG goals.
引用
收藏
页码:121 / 132
页数:12
相关论文
共 26 条
  • [1] Epidemiological data of treated end-stage renal failure in the European Union (EU) during the year 1995: report of the European Renal Association Registry and the National Registries
    Berthoux, F
    Jones, E
    Gellert, R
    Mendel, S
    Saker, L
    Briggs, D
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (10) : 2332 - 2342
  • [2] The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin
    Besarab, A
    Bolton, WK
    Browne, JK
    Egrie, JC
    Nissenson, AR
    Okamoto, DM
    Schwab, SJ
    Goodkin, DA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (09) : 584 - 590
  • [3] *CAN ER STUD GROUP, 1990, BMJ-BRIT MED J, V3, P573
  • [4] COLLINS AJ, 2002, KIDNEY INT S, V80, P44
  • [5] EVANS RW, 1990, JAMA-J AM MED ASSOC, V263, P825
  • [6] Foley R.N., 1998, AM J KIDNEY DIS, V31, P53
  • [7] Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy
    Foley, RN
    Parfrey, PS
    Morgan, J
    Barré, PE
    Campbell, P
    Cartier, P
    Coyle, D
    Fine, A
    Handa, P
    Kingma, I
    Lau, CY
    Levin, A
    Mendelssohn, D
    Muirhead, N
    Murphy, B
    Plante, RK
    Posen, G
    Wells, GA
    [J]. KIDNEY INTERNATIONAL, 2000, 58 (03) : 1325 - 1335
  • [8] Haemodialysis prescription, adherence and nutritional indicators in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)
    Hecking, E
    Bragg-Gresham, JL
    Rayner, HC
    Pisoni, RL
    Andreucci, VE
    Combe, C
    Greenwood, R
    McCullough, K
    Feldman, HI
    Young, EW
    Held, PJ
    Port, FK
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (01) : 100 - 107
  • [9] KLEIN JP, 1997, SURVIVAL ANAL TECHNI, P417
  • [10] Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin
    Levin, A
    Thompson, CR
    Ethier, J
    Carlisle, EJF
    Tobe, S
    Mendelssohn, D
    Burgess, E
    Jindal, K
    Barrett, B
    Singer, J
    Djurdjev, O
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (01) : 125 - 134